Cervicovaginal (Papanicolaou) smear findings in patients with malignant mixed Müllerian tumors

Diagnostic Cytopathology

Volumn 28, Issue 5, 2003, Pages 245-249

  Casey, Mary B ^a   Caudill, Jill L ^a   Salomão, Diva R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinosarcoma; Endometrial neoplasm; Malignant mixed M llerian tumor; Papanicolaou smear; Uterus

Indexed keywords

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; AGING; ARTICLE; CANCER CYTODIAGNOSIS; CELL TYPE; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MIXED MULLERIAN TUMOR; PAPANICOLAOU TEST; PRIORITY JOURNAL; SARCOMA; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY; UTERUS;

AGED; AGED, 80 AND OVER; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MIDDLE AGED; MIXED TUMOR, MULLERIAN; UTERINE NEOPLASMS; VAGINAL SMEARS;

EID: 0038078339     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10276     Document Type: Article

References (28)

1. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 1990;9:1-19.
2. Norris HJ, Roth E, Taylor HB. Mesenchymal tumors of the uterus: II. A clinical and pathologic study of 31 mixed mesodermal tumors. Obstet Gynecol 1966;28:57-63.
3. Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, Rudolph J. Uterine sarcomas: natural history, treatment, and prognosis. Cancer 1978;42:1152-1160.
4. Mortel R, Koss LG, Lewis JL Jr, D'Urso JR. Mcsodermal mixed tumors of the uterine corpus. Obstet Gynecol 1974;43:248-252.
5. Waxman M. Boyce JG, Macasaet MM, Lu T. Concurrence of malignant and benign heterologous mixed tumors of the uterus. Am J Clin Pathol 1982;77:631-637.
6. Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA. Evidence for a common etiology for endometrial carcinomas and malignant mixed Müllerian tumors. Gynecol Oncol 1998; 69:253-257.
7. van Rijswijk RE, Tognon G, Burger CW, Baak JP, Kenemans P, Vermorken JB. The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract. Int J Gynecol Cancer 1994;4:52-60.
8. Auerbach HE, LiVolsi VA, Merino MJ. Malignant mixed Müllerian tumors of the uterus: an immunohistochemical study. Int J Gynecol Pathol 1988;7:123-130.
9. Bitterman P, Chun B, Kurman RJ. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus: a clinicopathologic and immunohistochemical study. Am J Surg Pathol 1990; 14:317-328.
10. Costa MJ, Khan R, Judd R. Carcinoma (malignant mixed Müllerian [mesodermal] tumor) of the uterus and ovary: correlation of clinical, pathologic, and immunohistochemical features in 29 cases. Arch Pathol Lab Med 1991;115:583-590.
11. Geisinger KR, Dabbs DJ, Marshall RB. Malignant mixed Müllerian tumors: an ultrastructural and immunohistochemical analysis with histogenetic considerations. Cancer 1987;59:1781-1790.
12. George E, Manivel JC, Dehner LP, Wick MR. Malignant mixed Müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol 1991; 22:215-223.
13. Meis JM, Lawrence WD. The immunohistochemical profile of malignant mixed Müllerian tumor: overlap with endometrial adenocarcinoma. Am J Clin Pathol 1990;94:1-7.
14. Naib ZM. Exfoliative cytopathology. Third edition. Boston: Little, Brown and Co.; 1985.
15. Costa MJ, Tidd C, Willis D. Cervicovaginal cytology in carcinosarcoma [malignant mixed Müllerian (mesodermal) tumor] of the uterus. Diagn Cytopathol 1992;8:33-40.
16. An-Foraker SH, Kawada CY. Cytodiagnosis of endometrial malignant mixed mesodermal tumor. Acta Cytol 1985;29:137-141.
17. Massoni EA, Hajdu SI. Cytology of primary and metastatic uterine sarcomas. Acta Cytol 1984;28:93-100.
18. Parker JE. Cytologic findings associated with primary uterine malignancies of mixed cell types (malignant mixed Müllerian tumor). Acta Cytol 1964;57:316-320,
19. Meredith RF, Eisert DR, Kaka Z, Hodgson SE, Johnston GA Jr, Boutselis JG. An excess of uterine sarcomas after pelvic irradiation. Cancer 1986;58:2003-2007.
20. Peters WA III, Kumar NB, Fleming WP, Morley GW. Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet Gynecol 1984;63:550-556.
21. Varela-Duran J, Nochomovitz LE, Prem KA, Dehner LP. Postirradiation mixed Müllerian tumors of the uterus: a comparative clinicopathologic study. Cancer 1980;45:1625-1631.
22. Wheelock JB, Krebs HB, Scheneider V, Goplerud DR. Uterine sarcoma: analysis of prognostic variables in 71 cases. Am J Obstet Gynecol 1985;151:1016-1022.
23. Chuang JT, Van Velden DJ, Graham JB. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus: review of 49 cases. Obstet Gynecol 1970;35:769-780.
24. Demirkiran F, Arvas M, Erkun E, Kosebay D, Isiloglu H, Aktas E, Mil Z. The prognostic significance of cervico-vaginal cytology in endometrial cancer. Eur J Gynaecol Oncol 1995:16:403-409.
25. Schneider ML, Wortmann M, Weigel A. Influence of the histologic and cytologic grade and the clinical and postsurgical stage on the rate of endometrial carcinoma detection by cervical cytology. Acta Cytol 1986;30:616-622.
26. Mitchell H, Giles G, Medley G. Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol 1993;12:34-40.
27. Larson DM, Johnson KK, Reyes CN Jr, Broste SK. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol 1994;84:399-403.
28. Lozowski MS, Mishriki Y, Solitare GB. Factors determining the degree of endometrial exfoliation and their diagnostic implications in endometrial adenocarcinoma. Acta Cytol 1986;30:623-627.